Literature DB >> 63710

Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis.

C M Lockwood, A J Pinching, P Sweny, A J Rees, B Pussell, J Uff, D K Peters.   

Abstract

Nine patients with fulminating immune-complex crescentic nephritis were treated by a regimen of intensive plasma-exchange, steroids, and cytotoxic drugs. In five patients with severe renal failure there was early and rapid improvement in renal function; in one patient an early but extensive focal necrotising glomerulitis was arrested; in two patients improvement was delayed for 3 and 7 weeks and could not confidently be attributed to therapy; one patient, anuric at presentation, did not recover renal function. Follow-up renal biopsy specimens, obtained in three patients, showed no evidence of active disease. With the Clq-deviation test, circulating immune complexes were detected in five patients before treatment and had disappeared when renal function had improved and stabilised: these patients showed the best response to therapy. In three patients temporary withdrawal of plasma-exchange was followed by the reappearance of immune complexes in the circulation and was accompanied in two patients by deterioration in renal function; reintroduction of plasma-exchange was followed by elimination of immune complexes and further improvement in renal function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 63710     DOI: 10.1016/s0140-6736(77)91079-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

Review 1.  Clinical management and treatment of vasculitis.

Authors:  D Jayne
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Extra corporeal membrane oxygenation and plasmapheresis for pulmonary hemorrhage in microscopic polyangiitis.

Authors:  Hemant Shyam Agarwal; Mary Barraza Taylor; Marek Janusz Grzeszczak; Harold Newt Lovvorn; Tracy Earl Hunley; Kathy Jabs; Venkatramanan Shankar
Journal:  Pediatr Nephrol       Date:  2005-02-16       Impact factor: 3.714

3.  Lupus nephropathy and cardiopulmonary and hepatic dysfunctions in a child.

Authors:  Wasiu Adekunle Olowu
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

Review 4.  Role of therapeutic plasmapheresis in ANCA-associated vasculitis.

Authors:  Giles Walters
Journal:  Pediatr Nephrol       Date:  2015-05-19       Impact factor: 3.714

5.  Childhood vasculitis and plasma exchange.

Authors:  Elizabeth Wright; Michael J Dillon; Kjell Tullus
Journal:  Eur J Pediatr       Date:  2006-08-17       Impact factor: 3.183

Review 6.  Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.

Authors:  Damien Noone; Diane Hebert; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-09-05       Impact factor: 3.714

Review 7.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

8.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

9.  Crescentic glomerulonephritis in children.

Authors:  H M Jardim; J Leake; R A Risdon; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

10.  Defective splenic reticuloendothelial function in idiopathic membranous nephropathy.

Authors:  E McGinley; W Martin; N Henderson; J M Boulton-Jones
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.